Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

New AI-driven Toolkit Provides Insight into Infectious Pathogens

By LabMedica International staff writers
Posted on 20 Mar 2019
Scientists at the Francis Crick Institute (London, England) and UCL (London, England) have developed a new AI-driven platform that can analyze how pathogens infect human (‘host’) cells with the precision of a trained biologist.

The platform named HRMAn (‘Herman’), which stands for Host Response to Microbe Analysis, is open-source, easy-to-use and can be tailored for different pathogens including Salmonella enterica. More...
HRMAn uses deep neural networks to analyze complex patterns in images of pathogen and human cell interactions, pulling out the same detailed characteristics that scientists do by-hand.

The researchers used HRMAn to analyze the body’s response to Toxoplasma gondii, a parasite that replicates in cats and is thought to be carried by more than a third of the world’s population. Researchers in the Crick’s High Throughput Screening facility collected over 30,000 microscope images of five different types of Toxoplasma-infected human cells and loaded them into HRMAn for analysis. HRMAn detected and analyzed over 175,000 pathogen-containing cellular compartments, providing detailed information about the number of parasites per cell, the location of the parasites within the cells, and how many cell proteins interacted with the parasites, among other variables. The team also used HRMAn to analyze Salmonella enterica – a bacterial pathogen 16 times smaller than Toxoplasma, demonstrating its versatility for studying different pathogens.

“What used to be a manual, time-consuming task for biologists now takes us a matter of minutes on a computer, enabling us to learn more about infectious pathogens and how our bodies respond to them, more quickly and more precisely,” said Eva Frickel, Group Leader at the Crick, who led the project. “HRMAn can actually see host-pathogen interactions like a biologist, but unlike us, it doesn’t get tired and need to sleep!”

“Using the same sorts of algorithms that run self-driving cars, we’ve created a platform that boosts the precision of high volume biological data analysis, which has revolutionized what we can do in the lab,” said Artur Yakimovich, Research Associate in Jason Mercer’s lab at the MRC LMCB at UCL and co-first author of the study. Algorithms come in handy when the platform evaluates the image-based data in a way a trained specialist would. It’s also really easy to use, even for scientists with little to no knowledge of coding.”

Related Links:
Francis Crick Institute
UCL


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.